Template:Polymyxin B sulfate: Difference between revisions

Revision as of 03:28, 7 January 2014

Polymyxin B sulfate
NEOSPORIN^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

@@ Line 7: / Line 7: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Polymyxin B sulfate clinical pharmacology|Clinical Pharmacology]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Polymyxin B sulfate microbiology|Microbiology]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Polymyxin B sulfate indications and usage|Indications and Usage]]
@@ Line 15: / Line 17: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Polymyxin B sulfate adverse reactions|Adverse Reactions]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Polymyxin B sulfate drug interactions|Drug Interactions]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Polymyxin B sulfate overdosage|Overdosage]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Polymyxin B sulfate dosage and administration|Dosage and Administration]]